Chordate Medical Holding AB (publ) (OM:CMH) signed an agreement to acquire Neurolite on June 13, 2024. Chordate?s distributor and regulatory representative in Switzerland and Liechtenstein will be Neurolite AG, which specializes in delivering the latest medical technology solutions in neurology to hospitals and private clinics in the two countries.